OP0142 Rituximab in Systemic Sclerosis : Safety and Efficacy Data From the Eustar Network

doi 10.1136/annrheumdis-2018-eular.6024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Erratum to “Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients From a Single Centre Cohort: A EUSTAR Registration Initiative”

Acta Medica Portuguesa
Medicine
2018English

Efficacy and Safety of Rituximab for Systemic Lupus Erythematosus-Associated Immune Cytopenias. A Multicenter Retrospective Cohort Study of 71 Adults

American Journal of Hematology
Hematology
2018English

Effects of Treatment With Rituximab on Microcirculation in Patients With Long-Term Systemic Sclerosis

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2018English

Predictors of Disease Worsening Defined by Progression of Organ Damage in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Classification, Categorization and Essential Items for Digital Ulcer Evaluation in Systemic Sclerosis: A DeSScipher/European Scleroderma Trials and Research Group (EUSTAR) Survey

Arthritis Research & Therapy
2019English

Efficacy and Safety of Rituximab in Hepatitis-B Virus-Associated PLA2R-positive Membranous Nephropathy

Kidney International Reports
Nephrology
2018English

Systemic Sclerosis and Malignancy: A Review of Current Data

Journal of Clinical Medicine Research
2016English

Estimating Benefits From Immunesuppressive Treatment in Diffuse Cutaneous Systemic Sclerosis: Data From the Canadian Scleroderma Research Group

Open Journal of Rheumatology and Autoimmune Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy